Differential effects of RAS inhibitors associated with ACE gene polymorphisms in type 2 diabetic nephropathy.
Seki, N
Differential effects of RAS inhibitors associated with ACE gene polymorphisms in type 2 diabetic nephropathy. [electronic resource] - Diabetes research and clinical practice May 2006 - 135-41 p. digital
Publication Type: Clinical Trial; Journal Article
0168-8227
10.1016/j.diabres.2005.09.015 doi
Aged
Angiotensin II--blood
Angiotensin II Type 1 Receptor Blockers--pharmacology
Angiotensin-Converting Enzyme Inhibitors--pharmacology
Cross-Over Studies
Diabetes Mellitus, Type 2--blood
Diabetic Nephropathies--blood
Female
Genotype
Humans
Male
Peptidyl-Dipeptidase A--blood
Polymorphism, Genetic
Receptor, Angiotensin, Type 2--drug effects
Renin-Angiotensin System--drug effects
Transforming Growth Factor beta--blood
Differential effects of RAS inhibitors associated with ACE gene polymorphisms in type 2 diabetic nephropathy. [electronic resource] - Diabetes research and clinical practice May 2006 - 135-41 p. digital
Publication Type: Clinical Trial; Journal Article
0168-8227
10.1016/j.diabres.2005.09.015 doi
Aged
Angiotensin II--blood
Angiotensin II Type 1 Receptor Blockers--pharmacology
Angiotensin-Converting Enzyme Inhibitors--pharmacology
Cross-Over Studies
Diabetes Mellitus, Type 2--blood
Diabetic Nephropathies--blood
Female
Genotype
Humans
Male
Peptidyl-Dipeptidase A--blood
Polymorphism, Genetic
Receptor, Angiotensin, Type 2--drug effects
Renin-Angiotensin System--drug effects
Transforming Growth Factor beta--blood